CN106187809A - A kind of synthesis technique of levetiracetam intermediate - Google Patents
A kind of synthesis technique of levetiracetam intermediate Download PDFInfo
- Publication number
- CN106187809A CN106187809A CN201610569141.4A CN201610569141A CN106187809A CN 106187809 A CN106187809 A CN 106187809A CN 201610569141 A CN201610569141 A CN 201610569141A CN 106187809 A CN106187809 A CN 106187809A
- Authority
- CN
- China
- Prior art keywords
- amino
- synthesis technique
- reaction
- chloro
- ammonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/20—Preparation of optical isomers by separation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the synthesis technique of a kind of levetiracetam intermediate L 2 amino amides hydrochlorate, with 2 chloro-butyric acids as initiation material, first prepare 2 neoprene acid amide intermediate, 2 neoprene acid amide intermediate generate DL 2 amino-butanamide by reaction again, finally by splitting into salt and realize the synthesis of L 2 amino amides hydrochlorate, synthetic route is as follows:
Description
Technical field
The invention belongs to pharmaceutical intermediate preparation field, particularly to the synthesis technique of a kind of levetiracetam intermediate.
Background technology
Epilepsy is a kind of chronic recurrent caused by Different types of etiopathogenises of short duration brain function dysregulation syndrome, due to this disease
Sick prolonged and repeated outbreak has had a strong impact on quality of life and the social work ability of patient, causes the biggest to individual and society
Harm.Levetiracetam, chemical name (s)-a-ethyl-2-oxo-1-pyrrolidine acetamide, is that the exploitation of UCB. S.A. (BE) Bruxelles Belgium of Belgium is ground
A kind of new antiepileptic drugs of system, compared with similar drugs, levetiracetam has therapeutic index height, safety index height, can use
In being used individually, do not interact with other antiepileptic, side effect is slight, better tolerance, pharmacokinetics are every
The features such as index is excellent, are the antiepileptics uniquely with the special performance that prevention epilepsy occurs of report at present.
L-2-amino-butanamide is the important intermediate of synthesis antiepileptic levetiracetam, the most efficiently, economically
Preparation L-2-amino-butanamide is to reduce levetiracetam cost, it is achieved the key of the preparation efficient, economic of levetiracetam is asked
Topic.
In CN101130504A, it was recently reported that with 2-bromo-butyric acid as initiation material, prepare through ammonification, esterification, ammonolysis, fractionation
Target product.2-bromo-butyric acid and ammonia react generation 2-amino-butyric acid, due to generation ammonium bromide and 2-amino-butyric acid in separation
Difficulty, so needing refined, reaction yield is low, about 70% molar yield.Additionally in the reaction of ammonolysis, it is by 2-amino fourth
Acid first generates 2-amino-butyric acid methyl ester, then reacts with ammonia and obtains DL 2-amino-butanamide, and reaction rate is slow, logical ammonia reaction
24 hours, sometimes lead to ammonia and produce pressure, higher to equipment requirements, process safety is had an impact.Therefore this route also exists
Yield is low, the defect that process safety is poor.
For above-mentioned phenomenon, China Patent No. 201010558447.2 proposes in a kind of chiral drug levetiracetam
The synthesis technique of mesosome L-2-amino amides hydrochlorate, with 2-bromo-butyric acid as initiation material, first prepares 2-bromine butyramide intermediate,
2-bromine butyramide intermediate generates mixed whirlpool 2-amino-butanamide by reaction again, realizes L-2-aminoacyl finally by splitting into salt
The synthesis of amine hydrochlorate.Compared with existing synthesis technique, this synthesis technique reaction condition is gentle, reacts easily controllable, cost
Low, yield is higher, but by-product is more, affects the purity of finished product.
Therefore, research and develop a kind of yield that can improve reaction, reduce byproduct of reaction and reduce the levetiracetam of cost
The synthesis technique of intermediate L-2-amino amides hydrochlorate is necessary.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of yield that can improve reaction, reduces byproduct of reaction and fall
The synthesis technique of the levetiracetam intermediate of low cost.
For solving above-mentioned technical problem, the technical scheme is that the synthesis technique of a kind of levetiracetam intermediate,
Its innovative point is: with 2-chloro-butyric acid as initiation material, first prepares 2-neoprene acid amide intermediate, and 2-neoprene acid amide intermediate leads to again
Cross reaction and generate DL 2-amino-butanamide, finally by splitting into salt and realize the synthesis of L-2-amino amides hydrochlorate, synthesis
Route is as follows:
Concretely comprise the following steps:
(1) there is amidation process in 2-chloro-butyric acid and ammonia under thionyl chloride effect, generates 2-chlorobutamide;
(2) 2-chlorobutamide and ammonia react generation DL 2-amino-butanamide;
(3) the DL 2-amino-butanamide method by Resolution, is combined into L-TARTARIC ACID and salts out, and reaches isolated and purified
Purpose, remove resolving agent through alkalization and obtain optically active free alkali, and then become salt to obtain optically active L-2-aminoacyl
Amine hydrochlorate.
Further, there is amidation process in the 2-chloro-butyric acid described in step (1) and ammonia under thionyl chloride effect,
The ether solvent that reaction uses is methyl tertiary butyl ether(MTBE).
Further, the 2-chloro-butyric acid described in step (1), the quality mol ratio of thionyl chloride and ammonia be 1:1:2~
3, reaction temperature is 0-5 DEG C, and the response time is 5-7 hour, and reaction pressure is normal pressure.
Further, the 2-chlorobutamide described in step (2) and ammonia reaction temperature are 20-40 DEG C, and the response time is
10-15 hour.
It is an advantage of the current invention that:
(1) synthesis technique of levetiracetam intermediate of the present invention, with 2-chloro-butyric acid as raw material, greatly reduces the one-tenth of main material
This, and compared with existing synthesis technique, improve reaction yield, and by-product is less, and then improve the purity of finished product;This
Outward, in the method, reaction condition is gentle, reacts easily controllable, and process safety is greatly improved, and equipment requirements is low, is adapted to industry
Metaplasia is produced;
(2) synthesis technique of levetiracetam intermediate of the present invention, the ether solvent that reaction uses is methyl tertiary butyl ether(MTBE), with biography
The ether that system uses is compared, and the injury to human body is greatly reduced, and then further ensure that the safety of technique.
Detailed description of the invention
The following examples can make professional and technical personnel that the present invention is more fully understood, but the most therefore by this
Bright it is limited among described scope of embodiments.
(1) synthesis of 2-chlorobutamide
Embodiment one:
In the reaction bulb of 1000ml, adding 82.5g2-chloro-butyric acid, 165g mass concentration is ammonia and the 500ml methyl-tert of 30%
Butyl ether, cools to 0 DEG C, slowly drips 82.5g thionyl chloride under stirring, drips off rear insulated and stirred and reacts 5 hours, reaction
After completing, layering, organic layer is washed, is concentrated to dryness, obtains 2-chlorobutamide 72g.
Embodiment two:
In the reaction bulb of 1000ml, adding 82.5g2-chloro-butyric acid, 165g mass concentration is ammonia and the 500ml methyl-tert of 30%
Butyl ether, cools to 0 DEG C, slowly drips 82.5g thionyl chloride under stirring, drips off rear insulated and stirred and reacts 7 hours, reaction
After completing, layering, organic layer is washed, is concentrated to dryness, obtains 2-chlorobutamide 75g.
Embodiment three:
In the reaction bulb of 1000ml, adding 82.5g2-chloro-butyric acid, 247.5g mass concentration is ammonia and the 500ml methyl of 30%
Tertbutyl ether, cools to 0 DEG C, slowly drips 82.5g thionyl chloride under stirring, drips off rear insulated and stirred reaction 5 hours, instead
After should completing, layering, organic layer is washed, is concentrated to dryness, obtains 2-chlorobutamide 78g.
Table 1 below is to synthesize yield and the comparison or purity table of 2-chlorobutamide in embodiment 1-3.
Table 1 embodiment 1-3 synthesizes yield and the comparison or purity of 2-chlorobutamide
As can be seen from the above table, by this synthesis technique, the yield of 2-chlorobutamide can reach more than 85%, and purity carries the most significantly
Gao Liao, up to more than 95%;Meanwhile, each embodiment is compared, and embodiment 3 is most preferred embodiment.
(2) synthesis of DL 2-amino-butanamide
Embodiment one:
In the reaction bulb of 1000ml, add 165g2-chlorobutamide, 500g mass concentration is the ammonia of 30%, cool to
40 DEG C, stirring reaction 15 hours, after reaction completely, it is evaporated to do, residual solids methanol refines, and obtains DL 2-
Amino-butanamide 116g.
Embodiment two:
In the reaction bulb of 1000ml, add 165g2-chlorobutamide, 500g mass concentration is the ammonia of 30%, cool to
20 DEG C, stirring reaction 10 hours, after reaction completely, it is evaporated to do, residual solids methanol refines, and obtains DL 2-
Amino-butanamide 119g.
Embodiment three:
In the reaction bulb of 1000ml, add 165g2-chlorobutamide, 500g mass concentration is the ammonia of 30%, cool to
30 DEG C, stirring reaction 12 hours, after reaction completely, it is evaporated to do, residual solids methanol refines, and obtains DL 2-
Amino-butanamide 121g.
Table 2 below is to synthesize yield and the comparison or purity table of DL 2-amino-butanamide in embodiment 1-3.
Table 2 embodiment 1-3 synthesizes yield and the comparison or purity of DL 2-amino-butanamide
As can be seen from the above table, by this synthesis technique, the yield of DL 2-amino-butanamide can reach more than 70%, and purity is also
Substantially increase, up to more than 99%;Meanwhile, each embodiment is compared, and embodiment 3 is most preferred embodiment.
(3) synthesis of L-2-amino amides hydrochlorate
In 1000ml reaction bulb, add the DL 2-amino-butanamide of 80g.450ml mass concentration is the ethanol of 95%, heating
To 65 DEG C. adding 55gL-tartaric acid, stir 2 hours, filter, be the washing with alcohol of 95% by mass concentration, filter cake is L-2-ammonia
Base butyramide L-TARTARIC ACID salt solid, is suspended in ethanol, is passed through chlorine the most saturated, is stirred at room temperature 7 hours, filters, subtracts
Pressure is concentrated into about 200ml, the hydrogen chloride of dropping 30%, and regulation PH is 2, filters, washing with alcohol solid, and vacuum drying obtains L-
2-amino amides hydrochlorate 49g.
Table 3 below is yield and the comparison or purity table of the present invention and conventional synthesis L-2-amino amides hydrochlorate.
Table 3 present invention and the yield of conventional synthesis L-2-amino amides hydrochlorate and comparison or purity
As can be seen from the above table, compared with tradition, synthesis technique of the present invention, the yield of L-2-amino amides hydrochlorate is greatly improved
, more than 60% can be reached, purity also substantially increases, and can reach 99.8%.
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The skill of the industry
The art personnel simply explanation it should be appreciated that the present invention is not restricted to the described embodiments, described in above-described embodiment and description
The principle of the present invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, these
Changes and improvements both fall within scope of the claimed invention.Claimed scope by appending claims and
Its equivalent defines.
Claims (4)
1. the synthesis technique of a levetiracetam intermediate, it is characterised in that: with 2-chloro-butyric acid as initiation material, first prepare 2-
Neoprene acid amide intermediate, 2-neoprene acid amide intermediate generates DL 2-amino-butanamide by reaction again, finally by splitting into
Salt realizes the synthesis of L-2-amino amides hydrochlorate, and synthetic route is as follows:
Concretely comprise the following steps:
(1) there is amidation process in 2-chloro-butyric acid and ammonia under thionyl chloride effect, generates 2-chlorobutamide;
(2) 2-chlorobutamide and ammonia react generation DL 2-amino-butanamide;
(3) the DL 2-amino-butanamide method by Resolution, is combined into L-TARTARIC ACID and salts out, and reaches isolated and purified
Purpose, remove resolving agent through alkalization and obtain optically active free alkali, and then become salt to obtain optically active L-2-aminoacyl
Amine hydrochlorate.
The synthesis technique of levetiracetam intermediate the most according to claim 1, it is characterised in that: described in step (1)
2-chloro-butyric acid and ammonia under thionyl chloride effect, there is amidation process, the ether solvent of reaction employing is methyl tertbutyl
Ether.
The synthesis technique of levetiracetam intermediate the most according to claim 1, it is characterised in that: described in step (1)
2-chloro-butyric acid, the quality mol ratio of thionyl chloride and ammonia be 1:1:2~3, reaction temperature is 0-5 DEG C, and the response time is 5-7
Hour, reaction pressure is normal pressure.
The synthesis technique of levetiracetam intermediate the most according to claim 1, it is characterised in that: described in step (2)
2-chlorobutamide and ammonia reaction temperature be 20-40 DEG C, the response time is 10-15 hour.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610569141.4A CN106187809A (en) | 2016-07-20 | 2016-07-20 | A kind of synthesis technique of levetiracetam intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610569141.4A CN106187809A (en) | 2016-07-20 | 2016-07-20 | A kind of synthesis technique of levetiracetam intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106187809A true CN106187809A (en) | 2016-12-07 |
Family
ID=57493306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610569141.4A Pending CN106187809A (en) | 2016-07-20 | 2016-07-20 | A kind of synthesis technique of levetiracetam intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106187809A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002253294A (en) * | 2001-03-02 | 2002-09-10 | Mitsubishi Gas Chem Co Inc | Method for producing optically active aliphatic amino acid amide |
US20050182262A1 (en) * | 2004-02-18 | 2005-08-18 | Acharyulu Palle V.R. | Preparation of amino acid amides |
CN102020584A (en) * | 2010-11-25 | 2011-04-20 | 浙江沙星医药化工有限公司 | Method for synthesizing intermediate L-2-aminobutyrylamide hydrochloride of chiral drug levetiracetam |
CN105198768A (en) * | 2015-08-25 | 2015-12-30 | 江苏中邦制药有限公司 | Synthesis method for 2-aminobutanamide |
-
2016
- 2016-07-20 CN CN201610569141.4A patent/CN106187809A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002253294A (en) * | 2001-03-02 | 2002-09-10 | Mitsubishi Gas Chem Co Inc | Method for producing optically active aliphatic amino acid amide |
US20050182262A1 (en) * | 2004-02-18 | 2005-08-18 | Acharyulu Palle V.R. | Preparation of amino acid amides |
CN102020584A (en) * | 2010-11-25 | 2011-04-20 | 浙江沙星医药化工有限公司 | Method for synthesizing intermediate L-2-aminobutyrylamide hydrochloride of chiral drug levetiracetam |
CN105198768A (en) * | 2015-08-25 | 2015-12-30 | 江苏中邦制药有限公司 | Synthesis method for 2-aminobutanamide |
Non-Patent Citations (2)
Title |
---|
仇龙: "手性药物左乙拉西坦的合成工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
曹炜,郑小玲: "抗癫痫药物左乙拉西坦的合成研究进展", 《齐鲁药事》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102725249B (en) | Preparation and purification of iodixanol | |
CA2386297A1 (en) | Bicyclic amino acids as pharmaceutical agents | |
CN103539795A (en) | Apixaban polymorph and preparation method thereof | |
CN102079716B (en) | Preparation and purification of iodixanol | |
CN112209863A (en) | Large-scale preparation method of tafluprost | |
CN104356012B (en) | The preparation method of sarpogrelate hydrochloride light degradation impurity | |
CN102408468B (en) | Argatroban compound and preparation method thereof | |
CN105175329A (en) | New synthesis route and method of bedaquiline racemate | |
CN106432032B (en) | A kind of preparation method of Levetiracetam | |
CN1108029A (en) | Diamine salts of clavulanic acid | |
CN108218791A (en) | A kind of method that one kettle way prepares Lopinavir | |
CN106187809A (en) | A kind of synthesis technique of levetiracetam intermediate | |
MX346179B (en) | Process for the preparation of alkylphosphates. | |
JP3553335B2 (en) | Method for producing high quality tertiary amine | |
CN101146809A (en) | Process for preparing quinoline compounds and products obtained therefrom | |
CN105859648B (en) | A kind of method for preparing Peramivir intermediate | |
CN108314688A (en) | A kind of synthetic method of sitagliptin | |
CN108863831A (en) | A kind of hydrochloride for injection Propacetamol and preparation method thereof | |
RU2013156477A (en) | SUSTAINABLE CRYSTALLINE DOTAP CHLORIDE MODIFICATIONS | |
CN106905192A (en) | One planting sand storehouse must bent intermediate purification process | |
EP3474847B1 (en) | Processes for the preparation of eluxadoline | |
CN106187801A (en) | A kind of processing technique of L 2 amino-butanamide hydrochloride | |
CN103288671A (en) | Synthetic method of (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride | |
CN1062552C (en) | Cyclohexadiene derivatives | |
Lutz et al. | Further Studies on the Stability of β-Hydroxyethylamines toward the Oppenauer Oxidation. cis-and trans-1-Amino-2-indanols1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |